Medical device marketing is the rare niche where a good campaign from the wrong agency can generate a warning letter instead of a pipeline. Promotional claims about a device are bounded by its FDA clearance or approval: say more than the cleared intended use supports and the marketing itself becomes a regulatory violation. A medical device marketing agency therefore needs two competencies that rarely travel together: the craft of reaching clinicians, procurement committees and patients, and the discipline of doing it inside labeling and promotion rules. This page explains what the work involves, what separates specialists from generalists wearing a healthcare page, what moves price, and the evidence to demand.
The regulatory wall around device promotion
Everything starts from the device's regulatory status. A cleared or approved device may be promoted for its cleared intended use, and promotion beyond it (off-label promotion) is the classic violation. Claims need substantiation; comparative claims against competitor devices need evidence that survives scrutiny; and the FDA's device advice materials set out how promotion, labeling and advertising interact for different device classes. The practical consequence for a buyer: the agency does not need to be a law firm, but it must know that a claims-review workflow with your regulatory team is part of the job, budget time for it, and have survived it before. Ask candidates how claims got reviewed on their last device engagement, who had final sign-off, and what they did when regulatory killed their best creative. Agencies that have lived this answer with process and war stories. Agencies that have not will discover the rules on your budget, and possibly in your warning letter.
Three audiences, three different jobs
Device marketing splits by who makes the buying decision. Clinician-directed work is evidence-led: peer-reviewed data, conference presence, KOL relationships, procedure-focused content that respects the reader's expertise, and increasingly search visibility for the procedure and device-category queries clinicians actually use. Hospital procurement adds an economic-buyer layer: value-analysis committees want outcomes data, total cost of ownership and reimbursement clarity, so marketing here means arming your sales team with material that survives a committee. Patient-directed work, for devices where patients drive demand, is a different craft again, with plain-language education and its own advertising risk profile. Very few agencies are genuinely strong across all three. Decide which audience moves your revenue before you shortlist, and weight agencies by named work for that audience specifically, not by the breadth of their healthcare page.
What moves price, and the evidence to demand
Device retainers price on regulated-content labor: writers who can handle clinical evidence accurately, designers fluent in what a claim is, and the review cycles that compliance adds to every deliverable. Audience access is the second driver, since reaching clinicians through the right channels and events costs more than consumer media. Scope is the third: strategy and positioning, content and search, congress support, sales enablement, or the whole stack. Then apply the evidence test this directory applies to every trade, from a home services marketing agency to this one, because it is identical in shape: named device clients (under NDA constraints, at least the device category and audience), work you can examine, disclosed minimums, and a claims-review process they can describe without hedging. One more check is specific to this niche: ask who on the team has worked inside a device company or a regulated review process. One such person on the account changes everything about how smoothly the engagement runs.
Questions people ask about medical device marketing agency
Does a device marketing agency need FDA expertise?
It needs promotion-rule literacy, not regulatory-affairs credentials: the agency must know that claims are bounded by cleared intended use, that substantiation is required, and that your regulatory team holds final sign-off. Your company owns compliance; the agency's job is producing work that survives review without ten rounds of rewrites.
Can medical devices be marketed directly to patients?
For many devices, yes, and patient demand can pull prescriptions and procedures. But patient-directed promotion carries the same intended-use boundaries plus heightened scrutiny of risk presentation, and some device classes carry specific advertising requirements. Treat patient marketing as its own workstream with its own review path, not an afterthought to the clinician campaign.
What should we ask a device agency in the first meeting?
Which device clients they can name, at least by category and audience. How claims review worked on their last engagement and who had sign-off. Which clinician channels they have actually used and what performed. Who on the account team has worked inside a regulated review process. Vague answers to any of these predict an expensive education at your expense.
Does SEO work for medical device companies?
Yes, and it is often underused: clinicians and patients both search procedure and condition queries long before a sales conversation, and authoritative content that answers them builds pipeline the sales team never has to source. The constraint is that every page makes claims, so search content needs the same review path as any other promotion.